NASS has suspended all branch activity until further notice due to the current COVID19 outbreak. Please follow the link from our homepage for more information.
Discover the role of DMARDs in managing axial SpA (AS)
This information is for anyone with axial spondyloarthritis (axial SpA) including people with ankylosing spondylitis (AS)
Disease Modifying Anti Rheumatic Drugs (DMARDS)
DMARDs are only recommended for people with axial SpA (AS) where there is peripheral involvement. This means that DMARDs might help reduce symptoms in your hips, knees, ankles or arms.
There is no evidence that DMARDs such as methotrexate and sulfasalazine will help with axial SpA (AS) symptoms in the spine and neck.
Two types of biologic therapy have been licensed to treat axial SpA (AS) by NICE. Both work by reducing inflammation produced by the body
Biosimilar medicines are developed to be highly similar to a biologic medicine
Non-steroidal anti-inflammatory drugs (NSAIDs) reduce pain and inflammation